Testing gocovri for disability after brain radiation
Part of Brain & nervous system clinical trials.
This study tests a medication called Gocovri to see if it can help reduce disability caused by brain radiation damage. You may join if you have had brain radiation and have specific brain changes seen on an MRI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have had radiation therapy to the brain in the past.
- An MRI within the last 5 years must show certain changes in the brain's white matter.
- You need a caregiver who can help answer surveys.
- You must not be pregnant, breastfeeding, or planning to become pregnant during the study.
- You must not have severe kidney disease, a history of depression or suicidal thoughts, or be on certain medications (like amantadine or dexamethasone).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if bevacizumab works better than steroids for people with brain swelling caused by radiation. If you have this condition and meet certain health requirements, you may join.
This trial tests a new oral drug called XRD-0394 given together with radiation therapy for people with high-grade glioma, a type of aggressive brain tumor. The goal is to see if adding this drug makes radiation more effective.
This trial tests a virus-based treatment called MVR-C5252 for people whose high-grade glioma or glioblastoma has come back after standard therapy. The virus is injected directly into the tumor to try to kill cancer cells and boost the immune system. The goal is to see if it is safe and if it can shrink the tumor.
This trial tests a combination of a targeted drug called sacituzumab govitecan (Trodelvy) with radiation to the head for people with HER2-negative breast cancer that has spread to the brain. The goal is to see if this combination can shrink brain tumors and improve outcomes.
This study uses MRI scans and related brain/cognitive testing while you receive standard chemotherapy and radiation for a high-grade brain tumor. It aims to see how MRI measures and brain testing may relate to your treatment response or brain function.
This trial tests whether a special herpes virus (G207) combined with low-dose radiation can help children with high-grade brain tumors (gliomas). The virus is injected into the tumor to attack the cancer cells while radiation helps boost the effect.
Hear when a new Encephalopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.